EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melioidosis Queensland: An analysis of clinical outcomes and genomic factors

Ian Gassiep iD, Delaney Burnard, Budi Permana, Michelle J Bauer, Thom Cuddihy, Brian M Forde, Mark D Chatfield, Weiping Ling, Robert Norton, Patrick N A Harris

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Ian Gassiep und 9 weiteren Autor:innen. Beteiligte Einrichtung: The University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Herston, Queensland, Australia. Hauptthemen laut MEDLINE: Melioidosis, Burkholderia pseudomallei. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Australasian College of Physicians, Pathology Queensland Study and Education Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical and genomic epidemiology of melioidosis varies across regions.

Aim

To describe the clinical and genetic diversity of B . pseudomallei across Queensland, Australia.

Methods

Whole genome sequencing of clinical isolates stored at the melioidosis reference lab from 1996–2020 was performed and analysed in conjunction with available clinical data.

Results

Isolates from 292 patients were analysed. Bacteraemia was present in 71% and pneumonia in 65%. The case-fatality rate was 25%. Novel sequence types (ST) accounted for 51% of all isolates. No association was identified between the variable virulence factors assessed and patient outcome. Over time, the proportion of First Nation’s patients declined from 59% to 26%, and the proportion of patients aged >70 years rose from 13% to 38%.

Conclusion

This study describes a genomically diverse and comparatively distinct collection of B . pseudomallei clinical isolates from across Queensland, Australia. An increasing incidence of melioidosis in elderly patients may be an important factor in the persistently high case-fatality in this region and warrants further investigation and directed intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelioidosisBurkholderia pseudomalleiHumansAgedQueenslandAustraliaGenomics

Autor:innen und Institutionen

  • The University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Herston, Queensland, Australia.
  • Department of Infectious Diseases, Mater Hospital Brisbane, South Brisbane, Queensland, Australia.
  • Pathology Queensland, Royal Brisbane & Women's Hospital, Herston, Queensland, Australia.
  • Queensland Cyber Infrastructure Foundation, Brisbane, Queensland, Australia.
  • Herston Infectious Diseases Institute, Metro North Health, Queensland, Australia.
  • Pathology Queensland, Townsville University Hospital, Townsville, Queensland, Australia.

ORCID-Profile: Ian Gassiep

Förderung

  • Royal Australasian College of Physicians
  • Pathology Queensland Study and Education Committee

Zitieren

APA

Gassiep, I., Burnard, D., Permana, B., Bauer, M. J., Cuddihy, T., Forde, B. M., Chatfield, M. D., Ling, W., Norton, R., & Harris, P. N. A. (2023). Melioidosis Queensland: An analysis of clinical outcomes and genomic factors. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011697

Vancouver

Gassiep I, Burnard D, Permana B, Bauer MJ, Cuddihy T, Forde BM, et al. Melioidosis Queensland: An analysis of clinical outcomes and genomic factors. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011697

BibTeX
@article{Gassiep2023,
  author = {Gassiep, Ian and Burnard, Delaney and Permana, Budi and Bauer, Michelle J and Cuddihy, Thom and Forde, Brian M and Chatfield, Mark D and Ling, Weiping and Norton, Robert and Harris, Patrick N A},
  title = {Melioidosis Queensland: An analysis of clinical outcomes and genomic factors},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011697}
}
Kostenlos starten →